April 16, 2012
Allergan Inc. hit Watson Laboratories Inc., Apotex Inc. and four Novartis AG affiliates on Friday with a patent infringement suit in Texas federal court over glaucoma drops Combigan, marking a new battle over the heavily litigated eyedrops.